An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The investigators will provide Levetiracetam treatment to epilepsy subjects in Japan who are
judged to benefit from continued treatment with Levetiracetam by the investigators and who
are willing to continuously receive this drug.